ALLMedicine™ Chemotherapy-induced Oral Mucositis Center
Research & Reviews 56 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027418
BMC Cancer; Alsulami FJ, Shaheed SU
Apr 24th, 2022 - Oral mucositis (OM) is known to be the most common and challenging side effect of conditioning chemotherapy in haematopoietic cell transplant (HCT). This side effect causes significant morbidity and may delay the treatment plan, as well as increas...
https://doi.org/10.1111/odi.14217
Oral Diseases; Reyad FA, Elsayed NM et. al.
Apr 24th, 2022 - Evaluation of the effectiveness of Photobiomodulation(PBM) for chemotherapy-induced oral mucositis (OM) in leukemic children. A randomized controlled clinical study including forty-four leukemic children diagnosed with chemotherapy-induced OM at t...
https://doi.org/10.1016/j.ejps.2022.106182
European Journal of Pharmaceutical Sciences : Official Jo... Sun H, Zhou Y et. al.
Apr 12th, 2022 - Metformin (Met) is a first-line and essential treatment for type 2 diabetes, with anti-inflammatory effects. It has been reported Met could inhibit NF-κB activity and down-regulate the release of inflammatory factors. However, whether Met has a pr...
https://emedicine.medscape.com/article/1079570-overview
Mar 31st, 2022 - Practice Essentials Oral mucositis is a common complication of cancer chemotherapy. It begins 5-10 days after the initiation of chemotherapy and lasts 7-14 days. Chemotherapy-induced oral mucositis causes the mucosal lining of the mouth to atrophy...
http://emedicine.medscape.com/article/1079570-overview
Mar 31st, 2022 - Practice Essentials Oral mucositis is a common complication of cancer chemotherapy. It begins 5-10 days after the initiation of chemotherapy and lasts 7-14 days. Chemotherapy-induced oral mucositis causes the mucosal lining of the mouth to atrophy...
Drugs 4 results see all →
Clinicaltrials.gov 8 results
https://clinicaltrials.gov/ct2/show/NCT02050373
Jan 22nd, 2021 - This is a randomized clinical trial in which the proposed analysis will be performed from saliva samples of patients transplanted bone marrow, divided into two different groups (control and laser) and collected at different times during the hospit...
https://clinicaltrials.gov/ct2/show/NCT03203733
Nov 20th, 2020 - The degree of OM is assessed at eight intraoral locations, in accordance with the Oral Mucositis Assessment Scale (OMAS) (graded 0-3 for ulceration and 0-2 for erythema). 0 corresponds to "normal" while 3 and 2 are "sore >3 cm2" and "severe erythe...
https://clinicaltrials.gov/ct2/show/NCT04317183
Mar 23rd, 2020 - The study was designed as a randomized, controlled, clinical trial. patients who were undergoing to receive chemotherapy were divided into three groups: Group I: was given conventional treatment. Group II: was given topical oral gel of chamomile. ...
https://clinicaltrials.gov/ct2/show/NCT02539342
Mar 9th, 2020 - Oral mucositis, is a common and debilitating complication of cancer therapy. It is an inflammatory injury to the epithelial and sub-epithelial cells of the oral mucosa. The incidence and severity of oral mucositis depends on many factors including...
https://clinicaltrials.gov/ct2/show/NCT02606994
Feb 6th, 2019 - A pilot study showed that patients with chemotherapy-induced oral mucositis experienced accelerated healing of their oral mucositis by brushing with Oral Defense Toothpaste. In this study, participants experiencing up to grade 2 chemotherapy-induc...
News 2 results
https://www.onclive.com/view/articles_clinical_jun2008
Dec 5th, 2020 - Click here to view as PDF. PHASE III Second-Line Pemetrexed Does Not Provide Survival Advantage in Malignant Pleural Mesothelioma Pemetrexed seems to be one of the few therapies to exert positive effects in patients with malignant pleural mesot...
https://www.medscape.com/viewarticle/868718
Sep 13th, 2016 - Oral cryotherapy, which is the cooling of the mouth with cold consumables, is effective for the prevention of oral mucositis in the setting of fluorouracil (FU)-based chemotherapy for solid cancers, say experts in a Clinical Evidence Synopsis publ...